# Global X Genomics & Biotechnology ETF (GNOM)

> Source: Nexqual · https://nexqual.com/GNOM · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, Global X Genomics & Biotechnology ETF (GNOM), nexqual.com/GNOM" · informational, not investment advice.

**Price:** USD 65.58 (-0.65% on the day) · last close of Oct 23, 2026; US market after hours, not a live price. Prev close 66.01 · day 64.61–65.94 · 52w 41.16–74.19 · market cap null · NGM

## Key facts
- Total return with dividends: 1Y +52.1% vs S&P 500 +13.4%; 5Y -22.3% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +52.1% | -22.3% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +52.4% | -4.9% |
| Volatility (annualized) | 32.9% | 32.2% |
| Max drawdown | -18.2% (Jan 2026→Mar 2026) | -67.3% (Nov 2021→Mar 2025) |

## Peers
IDNA (iShares Genomics Immunology and) USD 40.91 -0.32% · EBIZ (Global X E-commerce ETF) USD 28.98 -1.32% · HEAL (Global X HealthTech ETF) USD 30.86 -0.10% · SNSR (Global X Internet of Things ETF) USD 45.96 +0.59% · FINX (Global X FinTech ETF) USD 24.45 -1.96%

## More
Full page: https://nexqual.com/GNOM · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Options: expected move (Cboe, 15-min delayed)

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 39.0% | ±9.2% |
| 2026-12-18 | 56 | 35.0% | ±11.4% |
| 2027-02-19 | 119 | 33.7% | ±15.4% |
| 2027-05-21 | 210 | 33.3% | ±19.8% |